The only test that reports clinical efficacy

Stop guessing.
Start treating with precision.

Stop guessing.
Start treating with precision.

NeuroPrecision Dx is the only pharmacogenomic test that analyzes both how the body processes a drug and whether it will work in the brain a living genetic profile that gets smarter as science advances.

NeuroPrecision Dx is the only pharmacogenomic test that analyzes both how the body processes a drug and whether it will work in the brain a living genetic profile that gets smarter as science advances.

4,257

Gene/Drug Variant Entries

14

Neurodiverse Conditions

33

Attributes Per Drug

The Full Picture

Brain response + metabolism indicators. The full picture.

Brain response + metabolism indicators. The full picture.

Other tests give you one dimension. NeuroPrecision Dx gives you both.

Pharmacodynamics (PD)

Will the drug work?

Brain efficacy

Analyzed across 33 attributes per drug, across 110+ medications. This is the dimension that matters most in neuropsychiatry and the one every other panel skips.

Pharmacokinetics (PK)

How will the body process it?

Metabolism and safety

CYP450 and beyond, with ADR risk scoring built in. Know not just if a drug works, but whether it’s safe for this patient’s specific metabolism.

How It Works

From order to outcome.

From order to outcome.

Simple online ordering, at-home saliva collection, AI-powered interpretation, and a clinical report in with cited drug rankings and treatment guidance the physician can act on immediately.

4-Step Process

4

Steps

0

Blood Draws

1 Simple Online Ordering Order through the platform, no lab account needed.

2 At-Home Saliva Collection No blood draw; patient collects at home and mails in.

3 AI + Clinical Interpretation 4,257 gene–drug entries with AI co-pilot review.

4 Actionable Clinical Report Cited drug rankings and guidance in 14 days.

Built to be used at the point of care. Not filed away.

Built to be used at the point of care. Not filed away.

Every feature designed so the result informs the next decision — immediately.

Multi-Factor Analysis

Evaluates PGx response, liver metabolism, and drug safety together for a complete clinical picture.

FDA and CPIC Aligned

Every recommendation backed by FDA and CPIC guidelines, with direct PubMed citations for each finding.

Dynamic Lifetime Profile

Results update free as the science database expands turning a single purchase into an evolving health asset.

Platform-Integrated Results

Genetic insights flow directly into OpenMind’s clinical decision support and Piper’s family health profile.

What It Maps

4,257 gene/drug–variant entries. Across 14 conditions.

4,257 gene/drug–variant entries. Across 14 conditions.

Built specifically for ADHD, Anxiety, Autism, Depression, and 10 additional neurodiverse conditions. Analyzed using Twist Exome 2.0 with 99.64% on-target accuracy.

01 Gene–drug efficacy and toxicity correlations — detailed consequence info per variant, not just gene names.


02 Drug metabolism profiles CYP450 and beyond, with full dosage range, frequency, and route.


03 Adverse drug reaction risk scores quantified, not categorical.


04 Personalized medication ranking by likelihood of success for this specific patient.


05 Epigenomic factors influencing behavioral trajectories.


06 Ethnicity and pediatric considerations built into every recommendation, not an afterthought.

How NeuroPrecision Dx stacks up.

How NeuroPrecision Dx stacks up.

How NeuroPrecision Dx stacks up.

Built for neuropsychiatry, not repurposed from a general panel.

Feature / Capability

NeuroPrecision Dx

Other Companies

Number of attributes

33

11

Gene information

Detailed gene & consequence info

Basic gene info only

Drug associations

Detailed with brand names & medications

Limited drug information

PK + PD

Both PK & PD available

Basic PK & PD only

Dosage information

Comprehensive dosage, route, frequency, study population

Limited

Ethnicity & pediatric consideration

✓ Considered

Not considered

Statistical significance & P-value

✓ Available

Not available

Built for neuropsychiatry. Not repurposed for it.

Built for neuropsychiatry. Not repurposed for it.

Four structural advantages that no general-purpose panel can replicate.

01 — Expertise

Deep neuropsychiatric expertise

Built from the ground up for ADHD, anxiety, autism, and depression.

02 — Accountability

Transparent, verifiable science

Direct PubMed citations for every finding and recommendation.

03 — Completeness

PD + PK together

Analyzes cognitive effectiveness and metabolic processing together.

04 — Integration

POD Health ecosystem

Genetic insights flow into OpenMind and Piper rather than sitting in a PDF.

Clinical Validation

Proven in practice. Validated at the point of care.

Proven in practice. Validated at the point of care.

14-patient pilot study — India, December 2025. Successfully mapped complex disease–gene–drug relationships, confirming NeuroPrecision Dx delivers consistent, clinically actionable pharmacogenomic profiles.

162–258

Outcome counts per patient across efficacy, response, and toxicity

71–83

Unique genes identified per patient — consistent rich profiles

76–88

Variants mapped per patient across the cohort

44–52

Drug interactions characterized per patient

Dr. Swapna Patil

Consultant Physiatrist, MRMC Gulbarga · Managing Director

One of my pediatric patients experienced significant adverse effects from a prescribed anti-seizure medication. We used the NeuroPrecision genetic test to support therapy selection. The report identified an alternative medication aligned with the patient’s pharmacogenomic profile. Following the therapy change, the patient showed notable improvement in tolerability, alertness, and day-to-day functioning within a few weeks.

Dr. Swapna Patil

Consultant Physiatrist, MRMC Gulbarga · Managing Director

One of my pediatric patients experienced significant adverse effects from a prescribed anti-seizure medication. We used the NeuroPrecision genetic test to support therapy selection. The report identified an alternative medication aligned with the patient’s pharmacogenomic profile. Following the therapy change, the patient showed notable improvement in tolerability, alertness, and day-to-day functioning within a few weeks.

Ready to end trial-and-error prescribing?

Ready to end trial-and-error prescribing?

Order NeuroPrecision Dx directly through the platform. No lab account, no complex setup.

7710 N FM 620 Bldg 13-D, Austin, TX 78726

Contact: info@podhealth.ai

© 2026 POD Health, Inc.

7710 N FM 620 Bldg 13-D, Austin, TX 78726

Contact: info@podhealth.ai

© 2026 POD Health, Inc.